Top compounds associated with response to NDUFB1


Feature Type Standardized
Nominal ANOVA
mRNA Axitinib GDSC1000 pan-cancer AAC -0.094 0.01
mRNA ISOX CTRPv2 pan-cancer AAC -0.081 0.01
mRNA BX-795 GDSC1000 pan-cancer AAC -0.088 0.01
mRNA Cetuximab GDSC1000 pan-cancer AAC -0.084 0.01
mRNA navitoclax:pluripotin (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.089 0.01
mRNA tacedinaline CTRPv2 pan-cancer AAC -0.094 0.01
mRNA Crizotinib GDSC1000 pan-cancer AAC -0.13 0.01
mRNA AICAR GDSC1000 pan-cancer AAC -0.08 0.01
mRNA selumetinib:UNC0638 (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.085 0.01
mRNA piperlongumine:MST-312 (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.086 0.02
Download CSV